MEZLOCILLIN

SynDRA canonical compound SYN0019483 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	gram-negative bacterial infections \| gram-positive bacterial infections
Disease area	infectious disease

All known targets

mezlocillin sodium monohydrate
mezlocillin sodium
Mezlocilline
Mezlocilina
BAY-F-1353
Baypen
Mezlin
Mezlocillinum
Mezlocillin (USAN/INN)
(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid
6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid
Multocillin
CHEBI:6919
OH2O403D1G
Bay-f 1353
DTXCID603316
mezlocillina
Meslocillin
Sodium, Mezlocillin
RefChem:925832
Bayf 1353
J01CA10
NCGC00167470-01
Mezlocilina [INN-Spanish]
Mezlocilline [INN-French]
Mezlocillinum [INN-Latin]
UNII-OH2O403D1G
Mezlocillin [USAN:INN:BAN]
EINECS 257-233-8
MEZLOCILLIN [MI]
MEZLOCILLIN [INN]
MEZLOCILLIN [USAN]
Epitope ID:120371
MEZLOCILLIN [VANDF]
MEZLOCILLIN [MART.]
SCHEMBL34075